Healthcare -
Biotechnology - NASDAQ - US
$ 1.27
1.6 %
$ 145 M
Market Cap
-0.77
P/E
FATE - CHANGE IN WORKING CAPITAL
Change in Working Capital FATE - Fate Therapeutics, Inc.
19.2 M
LAST VALUE
202.37%
2 YEAR CAGR
61.54%
5 YEAR CAGR
51.21%
10 YEAR CAGR